Cellectar Biosciences Inc... (CLRB)
NASDAQ: CLRB
· Real-Time Price · USD
4.37
-0.05 (-1.13%)
At close: Aug 15, 2025, 3:59 PM
4.41
0.92%
After-hours: Aug 15, 2025, 07:05 PM EDT
Cellectar Biosciences Income Statement
Financials in USD. Fiscal
year is
January - December.
| Fiscal Year | Q2 2025 | Q1 2025 | Q4 2024 | Q3 2024 | Q2 2024 | Q1 2024 | Q4 2023 | Q3 2023 | Q2 2023 | Q1 2023 | Q4 2022 | Q3 2022 | Q2 2022 | Q1 2022 | Q4 2021 | Q3 2021 | Q2 2021 | Q1 2021 |
| Period Ending | Jun 30, 2025 | Mar 31, 2025 | Dec 31, 2024 | Sep 30, 2024 | Jun 30, 2024 | Mar 31, 2024 | Dec 31, 2023 | Sep 30, 2023 | Jun 30, 2023 | Mar 31, 2023 | Dec 31, 2022 | Sep 30, 2022 | Jun 30, 2022 | Mar 31, 2022 | Dec 31, 2021 | Sep 30, 2021 | Jun 30, 2021 | Mar 31, 2021 |
Revenue | 309.02K | 309.02K | 309.02K | 330.37K | 330.37K | 330.37K | 330.37K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost of Revenue | 124.87K | 190.89K | 223.08K | 293.04K | 280.41K | 267.25K | 235.14K | 227.23K | 227.26K | 230.48K | 238.87K | 236.68K | 237.28K | 238.96K | 227.64K | 167.78K | 111.21K | 53.45K |
Gross Profit | 29.64K | -36.38K | -68.57K | 37.32K | 49.95K | 63.12K | 95.22K | -227.23K | -227.26K | -230.48K | -238.87K | -236.68K | -237.28K | -238.96K | -227.64K | -167.78K | -111.21K | -53.45K |
Operating Income | -38.51M | -46.18M | -51.78M | -51.58M | -47.67M | -42.26M | -38.96M | -33.84M | -32.24M | -31.38M | -28.81M | -27.31M | -25.32M | -23.91M | -24.13M | -22.01M | -20.1M | -17.69M |
Interest Income | 787.08K | 1.03M | 1.21M | 1.11M | 839.09K | 582.96K | 387.15K | 395.37K | 348.42K | 276.12K | 152.52K | 5.08K | 1.5K | 1.68K | 3.61K | 3.61K | 3.4K | 13.04K |
Pretax Income | -29.01M | -24.48M | -44.52M | -49.73M | -48.8M | -56.1M | -38.04M | -37.81M | -31.89M | -31.1M | -28.66M | -27.3M | -25.31M | -23.9M | -24.12M | -21.82M | -19.91M | -17.49M |
Net Income | -29.07M | -24.54M | -39.52M | -44.61M | -43.68M | -50.98M | -37.86M | -37.63M | -31.7M | -30.91M | -28.6M | -27.3M | -25.31M | -23.9M | -24.12M | -21.82M | -19.91M | -17.49M |
Selling & General & Admin | 20.99M | 23.7M | 25.26M | 23.27M | 17.54M | 13.16M | 10.68M | 8.11M | 8.44M | 9.39M | 9.59M | 9.16M | 8.61M | 7.07M | 6.54M | 6.43M | 5.78M | 5.53M |
Research & Development | 17.52M | 22.48M | 26.43M | 28.15M | 29.97M | 28.94M | 28.21M | 25.73M | 23.8M | 21.99M | 19.22M | 18.15M | 16.71M | 16.84M | 17.59M | 15.57M | 14.32M | 12.16M |
Other Expenses | n/a | n/a | n/a | 69.96K | 69.96K | 69.96K | 69.96K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Operating Expenses | 38.51M | 46.18M | 51.69M | 51.49M | 47.58M | 42.17M | 38.96M | 33.84M | 32.24M | 31.38M | 28.81M | 27.31M | 25.32M | 23.91M | 24.13M | 22.01M | 20.1M | 17.69M |
Interest Expense | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | 833.00 | 833.00 | 833.00 |
Selling & Marketing Expenses | n/a | n/a | -88.49K | -158.47K | -158.47K | -158.47K | -69.98K | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a | n/a |
Cost & Expenses | 32.47M | 46.18M | 51.78M | 51.58M | 47.67M | 42.26M | 38.96M | 33.84M | 32.24M | 31.38M | 28.81M | 27.31M | 25.32M | 23.91M | 24.13M | 22.01M | 20.1M | 17.69M |
Income Tax Expense | 66K | 66K | 111.21K | -14.79K | -55.99K | -55.99K | -225.24K | -225.24K | -188.2K | -188.68K | -65.08K | -6.4K | -22.03K | -40.59K | -58.49K | -57.16K | -37.37K | -18.32K |
Shares Outstanding (Basic) | 1.61M | 46.08M | 46.08M | 39.34M | 35.82M | 29.35M | 18.61M | 11.31M | 11.26M | 11.26M | 9.39M | 6.11M | 6.11M | 6.11M | 5.99M | 5.99M | 5.28M | 4.81M |
Shares Outstanding (Diluted) | 1.61M | 46.08M | 46.08M | 39.79M | 37.45M | 29.35M | 18.61M | 11.31M | 11.26M | 11.26M | 9.39M | 6.11M | 6.11M | 6.11M | 5.99M | 5.99M | 5.28M | 4.81M |
EPS (Basic) | -4 | -0.8 | -1.4 | -1.76 | -2.56 | -3.1 | -3.11 | -3.46 | -3.53 | -4.02 | -4.27 | -4.49 | -4.18 | -4.1 | -4.42 | -6.05 | -6.57 | -8.05 |
EPS (Diluted) | -3.99 | -0.78 | -1.38 | -1.74 | -2.55 | -3.1 | -3.11 | -3.46 | -3.53 | -4.02 | -4.27 | -4.49 | -4.18 | -4.1 | -4.42 | -6.05 | -6.57 | -8.05 |
EBITDA | -38.37M | -46.04M | -51.55M | -51.35M | -47.47M | -42.02M | -38.77M | -33.69M | -32.1M | -31.25M | -28.68M | -27.17M | -25.17M | -23.75M | -23.98M | -21.86M | -19.95M | -17.55M |
EBIT | -32.68M | -46.38M | -51.78M | -51.58M | -47.67M | -42.26M | -38.96M | -33.84M | -32.24M | -31.38M | -28.81M | -27.31M | -25.32M | -23.91M | -24.13M | -22.01M | -20.1M | -17.69M |
Depreciation & Amortization | 193.44K | 259.46K | 291.65K | 293.04K | 280.41K | 267.25K | 235.14K | 227.23K | 227.26K | 230.48K | 238.87K | 236.68K | 237.28K | 238.96K | 227.64K | 203.71K | 183.06K | 160.97K |